Navigation Links
Structure of TB Enzyme Points the Way to New Drugs: Study

Swiss scientists said Monday that they have further evidence to suggest that an enzyme secreted by the microbe that causes tuberculosis would make a promising target for new drugs to combat the deadly infectious disease.

The Swiss team first identified the enzyme, protein kinase G (PknG), as a promising drug target back in 2004.

At the time, they said that the protein is the secret weapon that enables the TB bug, Mycobacterium tuberculosis, to avoid being hunted down and destroyed by the body's immune system sentinels as most other pathogens are.

The protein apparently interferes with the functioning of the cells called macrophages that typically engulf and digest pathogens. Instead of absorbing and destroying the TB bacteria, the macrophages become host cells where the germ hides out.

In the same paper, the investigators said they had also identified a compound that could block the suspect protein, but they were concerned that by inhibiting this one protein, they would interfere with the action of other similar proteins secreted by the host cell.

"We wanted to be sure that inhibitors of mycobacterial PknG would not interefere with important host cellular functions," said Jean Pieters, a professor of biochemistry at the University of Basle in Switzerland and lead author of the paper.

So Pieters and colleagues decided to examine the chemical structure of the PknG molecule and the compound that inhibits it in atomic resolution, using a technique called X-ray crystallography.

They found that the compound acted on a segment of the protein that is unique to PknG -- not shared by any of the other 491 protein kinases that have been identified and sequenced thanks to the mapping of the human genome.

"Since we now know exactly what the requirements should be for a good blocker and how to avoid interference with host kinases, we should now be able to rationally des ign compounds that are highly effective against PknG," said Pieters.

Tuberculosis kills millions of people every year, and many millions more carry the bug in a latent form.

Antibiotics that are used to treat the illness are decades old, can be toxic and don't work on the bacteria in its dormant stage. What's more, some virulent strains of the airborne germ have emerged that are extensively drug resistant.

Pieters said that the new drugs by targeting different pathways than those used by existing antibiotics should side-step various problems with these drugs, specifically their inability to destroy the bacteria in its dormant form, which is one of the reasons that resistance has emerged.

The study appears in the Proceedings of the National Academy of Sciences.


'"/>




Related medicine news :

1. Relationship Between Genetic Structure And Quality of Life
2. Abnormal Brain Structure One Of The Reasons For Depression in Adolescents
3. Structure of the brain to increase risk for anxiety disorders
4. Changes In Brain Structure From Methamphetamine Abuse And HIV Infection
5. Almond Structure in the Brain Intrigues Researchers
6. Controversy over Fees Structure in Private Medical Colleges
7. Controversy Over The Fee Structure In Private Medical Colleges Surfaces Yet Again
8. Education Structure In Indian Schools To Be Revamped Soon
9. Neither Management Nor Students Happy With New Fee Structure
10. DNA-bound p53 Tumor Suppressor Protein Structure Determined
11. Structure of DNA-modifying enzyme In Small Pox Determined
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is ... vendors and unique items from across the nation, this holiday-themed event will raise funds ... by the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. ... recently contributed a medical article to the newly revamped Cosmetic Town journal ... spotlights the hair transplant procedure known as Follicular Unit Extraction (FUE). ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
(Date:10/4/2017)... 4, 2017  According to the Centers for Disease Control and Prevention ... . PhysicianOne Urgent Care is helping communities across Massachusetts ... , by offering no-cost* flu shots through the end of the month. ... health insurance regulations. ... to get a flu shot is by the end of October, according ...
(Date:10/2/2017)... Fla. , Oct. 2, 2017  AllianceRx Walgreens ... company formed by Walgreens and pharmacy benefit manager Prime ... its new brand, which included the unveiling of new ... , as well as at a few other ... the new brand to patients, some of whom will ...
Breaking Medicine Technology: